Shian Wu

Dr. Shian Wu

School of Life Science, Nankai University, Tianjin, China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
CLChen Ling
Chen Ling
YZYonggang Zheng
Yonggang Zheng
FYFeng Yin
Feng Yin
JYJianzhong Yu
Jianzhong Yu
JHJuan Huang
Juan Huang
DPDuojia Pan
Duojia Pan
The Hippo signaling pathway regulates organ size and tissue homeostasis from Drosophila to mammals. At the core of the Hippo pathway is a kinase cascade extending from the Hippo (Hpo) tumor suppressor to the Yorkie (Yki) oncoprotein. The Hippo kinase cascade, in turn, is regulated by apical membrane-associated proteins such as the FERM domain proteins Merlin and Expanded (Ex), and the WW- and C2-domain protein Kibra. How these apical proteins are themselves regulated remains poorly understood. Here, we identify the transmembrane protein Crumbs (Crb), a determinant of epithelial apical-basal polarity in Drosophila embryos, as an upstream component of the Hippo pathway in imaginal disk growth control. Loss of Crb leads to tissue overgrowth and target gene expression characteristic of defective Hippo signaling. Crb directly binds to Ex through its juxtamembrane FERM-binding motif (FBM). Loss of Crb or mutation of its FBM leads to mislocalization of Ex to basolateral domain of imaginal disk epithelial cells. These results shed light on the mechanism of Ex regulation and provide a molecular link between apical-basal polarity and tissue growth. Furthermore, our studies implicate Crb as a putative cell surface receptor for Hippo signaling by uncovering a transmembrane protein that directly binds to an apical component of the Hippo pathway.

17 August 2020 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
RMRuifang Ma
Ruifang Ma
OHOmid Haji-Ghassemi
Omid Haji-Ghassemi
DMDan Ma
Dan Ma
HJHeng Jiang
Heng Jiang
LLLianyun Lin
Lianyun Lin
Zhiguang YuchiZhiguang Yuchi
Zhiguang Yuchi

4 May 2022 in Progress in Neurobiology
Verified
Journal Article
Closed access
HWHui Wang
Hui Wang
YSYingchun Shang
Yingchun Shang
EWEnlin Wang
Enlin Wang
XXXinxin Xu
Xinxin Xu
QZQiyue Zhang
Qiyue Zhang
TZTao Zhang
Tao Zhang

25 September 2015 in Cell Research
Verified
Journal Article
Closed access
CLChaoyi Li
Chaoyi Li
LKLijuan Kan
Lijuan Kan
YCYan Chen
Yan Chen
XZXiudeng Zheng
Xiudeng Zheng
WLWeini Li
Weini Li
DCDahua Chen
Dahua Chen

12 August 2021 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PDF file
THTiansheng He
Tiansheng He
LDLonglong Dang
Longlong Dang
JZJiahui Zhang
Jiahui Zhang
JZJunqi Zhang
Junqi Zhang
GWGuiping Wang
Guiping Wang
XLXinqi Liu
Xinqi Liu

17 October 2023 in Journal of Biological Chemistry
Verified
Journal Article
Open access
JLJie Li
Jie Li
XLXiangxiang Liu
Xiangxiang Liu
BPBin Peng
Bin Peng
TFTingting Feng
Tingting Feng
WZWen Zhou
Wen Zhou
JLJing Li
Jing Li
O-linked N-acetylglucosamine (O-GlcNAc) glycosylation, a prevalent protein post-translational modification (PTM) that occurs intracellularly, has been shown to crosstalk with phosphorylation and ubiquitination. However, it is unclear whether it interplays with other PTMs. Here we studied its relationship with ADP-ribosylation, which involves decorating target proteins with the ADP-ribose moiety. We discovered that the poly(ADP-ribosyl)ation "eraser", ADP-ribose glycohydrolase (PARG), is O-GlcNAcylated at Ser26, which is in close proximity to its nuclear localization signal. O-GlcNAcylation of PARG promotes nuclear localization and chromatin association. Upon DNA damage, O-GlcNAcylation augments the recruitment of PARG to DNA damage sites and interacting with proliferating cell nuclear antigen (PCNA). In hepatocellular carcinoma (HCC) cells, PARG O-GlcNAcylation enhances the poly(ADP-ribosyl)ation of DNA damage-binding protein 1 (DDB1) and attenuates its auto-ubiquitination, thereby stabilizing DDB1 and allowing it to degrade its downstream targets, such as c-Myc. We further demonstrated that PARG-S26A, the O-GlcNAc-deficient mutant, promoted HCC in mouse xenograft models. Our findings thus reveal that PARG O-GlcNAcylation inhibits HCC, and we propose that O-GlcNAc glycosylation may crosstalk with many other PTMs.